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Abstract 
Background 
The liver fluke Fasciola hepatica is a major pathogen of livestock worldwide, causing huge 
economic losses to agriculture, as well as 2.4 million human infections annually. 
Results 
Here we provide a draft genome for F. hepatica, which we find to be amongst the largest 
known pathogen genomes at 1.3Gb. This size cannot be explained by genome duplication or 
expansion of a single repeat element, and remains a paradox given the burden it may impose 
on egg production necessary to transmit infection. Despite the potential for inbreeding by 
facultative self-fertilization, substantial levels of polymorphism were found, which highlights 
the evolutionary potential for rapid adaptation to changes in host availability, climate change 
or to drug or vaccine interventions. Non-synonymous polymorphisms were elevated in genes 
shared with parasitic taxa, which may be particularly relevant for the ability of the parasite to 
adapt to a broad range of definitive mammalian and intermediate molluscan hosts. Large-
scale transcriptional changes, particularly within expanded protease and tubulin families, 
were found as the parasite migrated from the gut, across the peritoneum and through the liver 
to mature in the bile ducts. We identify novel members of anti-oxidant and detoxification 
pathways and defined their differential expression through infection, which may explain the 
stage-specific efficacy of different anthelmintic drugs. 
Conclusions 
The genome analysis described here provides new insights into the evolution of this 
important pathogen, its adaptation to the host environment and external selection pressures. 
This analysis also provides a platform for research into novel drugs and vaccines. 
Background 
The digenean trematode Fasciola hepatica is one of the most important pathogens of 
domestic livestock and has a global distribution [1-4]. The disease, fasciolosis, results in huge 
losses to the agricultural industry associated with poor food conversion, lower weight gains, 
impaired fertility and reduced milk (cattle) and wool (sheep) production. Heavy, acute 
infections can result in death, particularly in sheep and goats. Economic losses attributable to 
F. hepatica infection have been estimated at more than US$3 billion per annum worldwide 
[5,6], although even this estimate may be conservative as F. hepatica infection modulates its 
host’s immune response and its ability to resist or eliminate common microbial pathogens 
[7,8]. Fasciolosis is also an important zoonosis in regions where agricultural management 
practices are less advanced, particularly in South America and North Africa [3,9]. It is 
estimated that between 2.4 and 17 million people are infected with this liver fluke worldwide, 
with a further 91 million people living at risk, resulting in fasciolosis being included on the 
WHO list of major neglected tropical diseases [1-3]. 
The zoonotic potential of F. hepatica is enabled by its remarkable ability to infect and mature 
in an extensive range of terrestrial mammals. Thus, while the typical definitive host for F. 
hepatica is one of many species of domestic or wild ruminant that ingest contaminated 
pasture (Figure 1), F. hepatica is also able to exploit disparate host species including humans 
and rodents, and has rapidly adapted to novel hosts such as llamas and kangaroos, which it 
has recently come into contact with in South America and Australia, respectively [10]. This is 
in contrast to most digenean trematodes, such as the human pathogen Schistosoma mansoni, 
which have a far more restricted host range. F. hepatica can also adapt rapidly to drug 
interventions and the emergence of resistance within F. hepatica populations to 
triclabendazole (TCBZ) is of major concern, since most drugs used against other digeneans 
are only partly protective against F. hepatica [10]. TCBZ is also the only drug currently 
available that is able to protect livestock and humans against early stage juveniles, which 
cause significant pathology as they migrate through the liver. The ability of F. hepatica to 
adapt rapidly to novel hosts or to drug interventions is perhaps more remarkable given that F. 
hepatica is a hermaphrodite that can facultatively self-fertilize and so F. hepatica populations 
might be expected to lose genetic diversity through inbreeding that would be an essential 
basis for adaptation. 
Figure 1 Fasciola hepatica lifecycle. (a) Graphical representation of the F. hepatica 
lifecycle (modified from [76]). a1 Definitive host – host range includes cattle, sheep and 
humans. a1.1 Parasite excysts in the intestine of the definitive host, releasing newly excysted 
juveniles (NEJ) that migrate across the intestinal wall, through the peritoneal cavity to the 
liver. a1.2 NEJ migrate through the liver parenchyma, increasing in size to juvenile flukes as 
they migrate a1.3 into the bile ducts a1.4, where they grow and develop into fully mature 
adults. a2 Eggs are released in the faeces and develop on pasture. a3 From each embryonated 
egg hatches a single miracidium, which infects the snail intermediate host (Galba truncatula). 
a4 Within the snail the parasite undergoes a clonal expansion, developing through the 
sporocyst, rediae and cercariae lifecycle stages. a5 Cercariae are released from the snail and 
encyst on vegetation as dormant metacercariae, which are ingested by the definitive host a1. 
(b-d) Graphical representation of the development of the parasite through the definitive host. 
(b) The parasite increases dramatically (~1000-fold) in size over the course of approximately 
12 weeks, from NEJ to adult. (c) Expression of key enzymes of metabolism reveals how the 
growth of the parasite limits oxygen diffusion into the parasite tissue, switching from aerobic 
energy metabolism (Kreb’s cycle; PK: pyruvate kinase; SD: succinate dehydrogenase) to 
aerobic acetate production (ME: malic enzyme) to anaerobic dismutation (PEPCK: 
phosphoenolpyruvate carboxykinase), as shown by the log fold change in expression between 
the lifecycle stages (expression is shown relative to metacercariae lifecycle stage). (d) In 
addition to the dramatic growth, maturation of the parasite occurs, with the fully mature adult 
digesting host blood, which provides the nutrient for massive egg production (approximately 
20,000 eggs per day per parasite), as shown by the increased expression of the egg shell 
component, vitelline. 
Here we provide a genome assembly for F. hepatica and assess genome-wide polymorphism 
and transcriptional profiles in order to identify key features of its genome that underlie its 
ability to migrate through different physiological environments, to parasitize different host 
species, and to respond rapidly to external selection pressures. 
Results and discussion 
A large genome with high gene polymorphism 
A draft genome for F. hepatica was generated with an assembled length of approximately 
1.3Gb (Table 1). The genome of F. hepatica is considerably larger than that of other 
sequenced digenean parasites – Schistosoma spp (363 - 397 Mb), Clonorchis sinensis (547 
Mb) or Opisthorchis viverrini (634.5 Mb) [11-16] – and is one of the largest pathogen 
genomes sequenced to date. Genome size does not appear to be related to chromosome 
number among trematodes; F. hepatica has 10 pairs of chromosomes [17], S. mansoni and O. 
viverrini have 8 pairs and 6 pairs of chromosomes, respectively [18,19], but C. sinensis, also 
with a smaller genome than F. hepatica, has 28 pairs [20]. Comparative analysis with other 
sequenced trematode species indicated that the mean number of exons per gene is comparable 
between species, but that mean exon and intron lengths tend to increase with genome size 
(Additional file 1: Table S1). Most core eukaryotic genes appeared as single copy evidenced 
by both CEGMA (Additional file 2: Table S2) and analysis of read coverage (Additional file 
3: Figure S1), suggesting that the large genome size of F. hepatica has not arisen by genome 
duplication. At least 32% of the genome was estimated to consist of repetitive DNA, which is 
consistent with other trematode genomes [11-15]. The median repeat length was 26 bp 
(Additional file 4: Figure S2) and we observed retrotransposons, including 27Mbp of long 
terminal repeats and 59Mbp of long interspersed elements (LINEs); however, there was no 
obvious expansion of a single repeat element to account for the large genome size. A LINE 
RTE BovB repeat, previously found in ruminants, was observed distributed widely across the 
genome (at least 67,000 full or partial copies in total across approximately 30% of the 
scaffolds and totalling 28.1Mbp). This was not due to contamination by host DNA, since no 
other host sequence, such as sheep mitochondrial sequence, could be identified either in the 
assembly or in individual reads. BovB has previously been reported as exhibiting horizontal 
transfer between snakes and ruminants and its presence in F. hepatica suggests that transfer 
of BovB elements between disparate vertebrate taxa may be facilitated by digenean infection 
[21]. 
Table 1 Fasciola hepatica assembly statistics 
Metric Value
Scaffold N50 204Kbp (REAPR 155Kbp1) 
Number of scaffolds ≥3Kbp 20,158 
Number of scaffolds ≥1Kbp 45,354 
Contig N50 (≥100 bp) 9.7Kbp 
Number of contigs (≥100 bp) 254,014 
Total assembly length 1.275Gbp 
Total length of gaps 91.6Mbp 
Repetitive content 32% 
Number of RNAseq-supported gene models 22,676 (15,7402) 
Mean number of exons/gene 5.3 
Mean exon size (95% range) 303 bp (36 bp - 1369 bp) 
Mean intron size (95% range) 3.7Kbp (33 bp - 17.5Kbp) 
Proportion CEGMA core eukaryotic genes found 90% 
1 - N50 following breakage of some scaffolds at areas to low support. Both assemblies are available from ENA 
under project accession PRJEB6687. 
2 - Number of non-overlapping, distinct genome intervals covered by RNAseq-supported gene models. 
We investigated levels of polymorphism among F. hepatica genes by re-sequencing the 
genomes of individual fluke from each of five isolates, all from the UK. Substantial 
polymorphism among isolates was observed; 48% of genes exhibited at least one non-
synonymous SNP and the level of non-synonymous nucleotide diversity, pi, averaged across 
21.8Mbp of coding sequence, was 5.2 x 10−4 (i.e. two randomly sampled sequences differed 
approximately every 1900bp). By comparison, this figure is higher than in humans [22], 
similar to most vertebrates [23] and, on limited data, smaller than some parasitic nematode 
populations [24]. Although F. hepatica is a self-fertilizing hermaphrodite, and so has the 
potential to inbreed and lose genetic diversity, our data show that F. hepatica populations, as 
a whole, harbour substantial genetic variation. A likely explanation is that parasite 
populations are typically large, often larger than that of their hosts, which greatly slows any 
enhanced effects of genetic drift caused by self-fertilization [25]. 
By analysing the distribution of genetic diversity amongst F. hepatica genes, we found higher 
non-synonymous polymorphism in genes shared with parasitic cestodes and digeneans 
relative to orthologs shared with the free-living turbellaria (Figure 2a and Additional file 5: 
Table S3 and Additional file 6: Table S4). These data suggest high adaptability in F. hepatica 
genes that mediate infection and survival in the host environment, which is consistent with F. 
hepatica’s ability to infect a range of both mammalian and molluscan hosts [3,9,10]. We then 
assessed whether high non-synonymous polymorphism was associated with particular 
biological functions and discovered a marked over-representation of biological processes 
associated with axonogenesis and chemotaxis among the top 1% quantile of polymorphic 
genes (Figure 2b and Additional file 7: Table S5 and Additional file 8: Table S6). These 
genes included cadherin, semaphorin, fascilin and rabconnectin, which are involved in cell 
adhesion and migration of neurons [26-28]. The high polymorphism observed in 
chemosensory and neural development pathways may relate to the challenge faced by F. 
hepatica in locating its snail host or in tissue migration in its vertebrate host, and with 
variation in host preference within parasite populations [29,30]. Such polymorphism may be 
particularly relevant for development of new anthelmintics targeting the parasite’s 
neuromuscular system [31]. 
Figure 2 Polymorphism within Fasciola hepatica. (a) Levels of non-synonymous 
polymorphism for F. hepatica genes exhibiting orthology with Clonorchis, Schistosoma, 
Schmidtea or Echinococcus indicated within the phylogenic tree. Numbers by branches refer 
to numbers of orthologous groups specifically shared by that branch; e.g. 464 orthologs are 
shared only between Fasciola and Clonorchis, a further 388 are also shared with Schistosoma 
but not with Schmidtea or Echinococcus etc. Branches not drawn to scale. Polymorphism is 
significantly (p < 0.001) higher in Fasciola orthologs shared amongst the digenean and 
cestode parasites Clonorchis, Schistosoma and Echinococcus (green, red and blue crosses, 
respectively) relative to orthologs conserved with the turbellarian Schmidtea (black dots). (b-
c) Directed acyclic graphs indicating over-representation of biological processes within the 
top 1% most polymorphic genes, based on non-synonymous diversity. Shaded boxes 
indicated significant (p < 0.01) over-representation. Black and blue arrows indicate, 
respectively, ‘is a’ and ‘part of’ relationships between terms. 
Expression patterns from multi-gene families reveal important developmental 
host-parasite interactions 
In order to understand how F. hepatica has adapted to survive within its vertebrate host, we 
characterised its developmental time-course of gene expression using RNAseq. Progressively 
more genes were differentially expressed, and with larger fold-changes, following initial 
infection and subsequent development in the host; i.e. associated with excysting of the 
metacercaria stage to form the newly excysted juvenile (NEJ), traversal of the intestinal wall 
and penetration of the liver as an immature tissue-migrating parasite (Figure 3a). Thereafter, 
the transition from these immature parasites to mature adults living in the bile duct was 
accompanied by further changes in the overall profile of differentially expressed genes, but 
not in the number of genes differentially expressed relative to metacercariae. Known aspects 
of Fasciola biology were recapitulated in our expression data. Thus, as the parasite grows, 
diffusion of oxygen into parasite tissue is limiting and our expression analysis confirmed the 
switch from aerobic to anaerobic metabolism (Figure 1b and c) [32]. Similarly, our data 
confirmed that the production of vitelline, the egg shell component, is limited to the mature 
parasites (Figure 1d). 
Figure 3 Expression of genes exhibiting at least a 16-fold difference in expression 
between any two developmental stages and grouped by hierarchical clustering. (a) 
Heatmap with up-regulation in blue and down-regulation in red relative to metacercariae. 
Colors to left of heatmap correspond to different clusters. (b) Expression of genes within 
each cluster on a log2 scale. The number of genes and the enrichment of biological processes 
are shown for the most specific terms within the gene ontology structure and with a 
significance of <0.1%. GO:0006508 Proteolysis is shown in brackets for clusters where it 
appears with a significance of 0.1% < p < 1%. 
To explore novel processes associated with developmental changes, genes were clustered 
based on expression pattern (Figure 3b). Several biological processes were greatly down-
regulated in maturing and adult parasites relative to metacercariae (Cluster 12, Figure 3), 
including molecules involved in cell adhesion (cadherins, integrins) and cytoskeletal proteins 
(talins) that could play an important role in sensing changes in the physiological environment 
and rapidly initiating excystment following ingestion by the definitive host. Clusters showing 
strongest patterns of differential expression (both up and down regulation) were markedly 
over-represented by peptidases and terms associated with regulation of peptidase activity 
(Clusters 2, 8, 10 and 11, Figure 3). Genes associated with F. hepatica structure, particularly 
protein polymerisation and microtubule based movement, such as tubulin, dynein and surface 
tegumental genes, were highly up-regulated in immature and adult fluke relative to earlier 
stages (Clusters 1 and 3, Figure 3b and Additional file 9: Table S7, Additional file 10: Table 
S8 and Additional file 11: Table S9). Our data show that, across the transcriptome as a whole, 
the strongest changes in expression were observed amongst different members of the 
multigenic protease and tubulin families, as detailed below. 
Peptidases play essential roles in parasite infection, tissue migration and feeding [33]. F. 
hepatica is unique amongst helminth parasites because it relies almost exclusively on the 
secretion of papain-like cysteine peptidases (Clan A, family C1), classes cathepsins L (FhCL) 
and cathepsins B (FhCB) [33,34]. These two peptidase classes, however, have expanded and 
diverged to form multigenic families, all of which have were found within our assembly 
(Figure 4a and Additional file 12: Figure S3). Our data show that FhCL peptidases form 
clades with a total of 17 members and we found that each clade has a distinctive peptidolytic 
activity based on residues that make up the S2 sub-site of the active site (Additional file 12: 
Figure S3 [35,36]). Members within each clade exhibited a concerted pattern of expression 
that can be correlated with migration of the parasite through different tissues where they 
would encounter a different profile of macromolecular substrates. For example, FhCL3s are 
known to exhibit a unique collagenolytic activity required to disrupt the interstitial matrix and 
their secretion in high amounts enable NEJs to traverse the intestinal wall and penetrate the 
liver capsule [33,34,37]. Our data reveals that the FhCL3 clade has expanded to five 
members that are all abundantly expressed by NEJs and share critical residues (H61, W67 
and V205) within the active site, suggesting that enlargement of this family has been driven 
by the need to produce plentiful collagenolytic peptidase at this critical time in the parasite’s 
life cycle. Conversely, members of the FhCL1 clade, the largest with six members, were not 
expressed during the early migratory stages but all showed an increase in expression as the 
parasite matures (Figure 4b). Mature adults are obligate blood feeders [30,37] and secrete 
copious amounts of FhCL1 and, correspondingly, evolution of the FhCL1 active site 
(residues N61, L/F67 and L/M205) has resulted in loss of collagenolytic activity but a gain in 
the ability to effectively digest blood proteins, particularly hemoglobin, which are the mature 
parasite’s prime source of nutrients required for egg production [30,37]. 
Figure 4 Analysis of the cysteine proteases belonging to F. hepatica cathepsin L (FhCL) 
and cathepsin B (FhCB) clades and their activators, the asparaginyl 
endopeptidases/legumains. (a) Representation of the number of genes identified for each 
FhCL clade and for the groups of FhCB and legumain genes, based on analysis by BLAST 
and manual annotation. The nucleotide identity is shown for each clade/ group of genes 
(Clustal Omega). (b-d) Graphical representation of the expression for FhCL, FhCB and 
legumain proteases across the F. hepatica lifecycle in reads per kilobase per million (RPKM). 
In the case of the FhCL gene expression, all the genes within the same clade showed a similar 
pattern of expression, and so are represented here as an average log RPKM. Likewise in the 
case where multiple gene models were identified for a particular gene, which showed a 
similar level of expression, are represented here as an average log RPKM. 
Unlike the FhCL peptidases, the FhCB family consists of a single clade of seven members. 
Nevertheless, these peptidases were also temporally regulated (Figure 4c) such that three 
members (FhCB1, FhCB2 and FhCB3) exhibited parallel expression patterns to FhCL3 and 
were thus highly expressed in the NEJs and down-regulated as the parasites matured. These 
data suggest a concerted role for FhCLs and FhCBs in the early infection stage. Also, the 
constitution and specific expression of a family of peptidases, asparaginyl endopeptidases or 
legumains that are responsible for the processing of the inactive FhCL and FhCB zymogens 
to functional enzymes [38] suggest specific and important developmental roles for these 
peptidases (Figure 4d). Thus, legumain 1, which was the most highly expressed member in 
NEJs could be required for activation of the FhCL3 and FhCB 1/2/3 peptides at the time the 
parasite emerges from its encysted stage in the intestine and initiates infection. Furthermore, 
legumain 3, which was switched on late in parasite development, is the prospective candidate 
for activating the FhCL1, FhCL2 and FhCL5 in mature blood-feeding adult parasites. 
Our data highlight tubulins as another multigenic family that exhibit amongst the highest log 
fold changes in expression throughout F. hepatica development. We identified the full 
complement of five α-tubulin and six β-tubulin isotypes [39,40] and found duplication of β-
tubulin isotype 3 (Figure 5a,b). Basal expression levels revealed two functional subsets of β-
tubulin molecules; high constitutive expression of β-tubulin isotypes 2, 3a, 3b and 4 suggests 
they play an essential role in general microtubule structure and function, while a more 
specialized role is implicated for β-tubulin isotype 1 and 5, which were particularly expressed 
in the immature liver stages. Tubulins are known targets of benzimidazole (BZ) drugs 
[40,41], which include TCBZ, and the unique nature of the interaction of F. hepatica with 
TCBZ remains undefined. Protein similarity searches with the closely related species C. 
sinensis and S. mansoni, which are refractory to TCBZ, identified six and ten β-tubulin gene 
models, respectively. While F. hepatica β-tubulin isotypes 1–4 show >95% similarity with 
multiple sequences from these species, that observed for β-tubulin isotype 5 and 6 was <70% 
(Additional file 13: Table S10). Of the two BZ-derived drugs effective against F. hepatica, 
TCBZ targets immature and adult fluke whilst albendazole (ABZ), a widely used anti-
nematode drug, kills only adult stages. Field isolates of F. hepatica that demonstrate 
resistance to ABZ remain susceptible to TCBZ suggesting independent modes of action [42] 
that may be related to the diverse β-tubulin isotypes found in this parasite. 
Figure 5 Expression of tubulin genes. (a-b) Graphical representation of the expression of 
the tubulin genes across the F. hepatica lifecycle represented by α-tubulins (a) and β-tubulins 
(b). The expression of each tubulin isotype (iso) is shown in reads per kilobase per million 
(RPKM), which were calculated as an average log RPKM value for the multiple 
transcriptome datasets at each lifecycle stage. 
Anti-oxidant and detoxification systems 
We investigated the evolution of anti-oxidant systems in F. hepatica, which are essential for 
adaptation to the host environment. Thus, as the parasite rapidly develops and enters different 
aerobic/anaerobic environments, anti-oxidant systems are critical not only for the 
detoxification of reactive oxygen and nitrogen (ROS, RNS) generated by endogenous cellular 
metabolism but also as a frontline defence against superoxide and nitric oxide radicals 
released by host immune effector cells such as macrophages, eosinophils and neutrophils 
[43,44]. Parasitic platyhelminths express genes encoding superoxide dismutase (SOD) which 
dismutates superoxide radicals to H2O2 but they do not possess catalase, the enzyme 
responsible for converting H2O2 to water and oxygen (although a catalase gene is present in 
the genome of free-living flatworms, such as Schmidtea mediterranea). A catalase gene was 
not found in the F. hepatica genome, which is consistent with other parasitic platyhelminths, 
where the function of peroxide detoxification has been supplanted by the newly discovered 
thiol-dependent peroxiredoxin and its reducing partner thioredoxin [45]. The presence of the 
gene encoding the recently described thioredoxin glutathione reductase (TGR; Additional file 
14: Table S11), together with the absence of distinct thioredoxin reductase and glutathione 
reductase genes verified that TGR is the sole reductive enzyme that links the thioredoxin-
dependent and glutathione-dependent anti-oxidant defence systems in this parasite as 
observed in other platyhelminths [43,46,47]. The pivotal position of TGR between these two 
essential anti-oxidant systems makes it a promising target for the development of new anti-
trematode drugs [46]. Included in the repertoire of F. hepatica anti-oxidants are genes 
encoding SOD, glutathione transferases (GSTs) and three fatty acid binding proteins (FABP; 
Additional file 14: Table S11). With the exception of the GSTs, we found that in F. hepatica 
each of these components is encoded by a single gene, which is in stark contrast to the 
expanded anti-oxidant gene families in the closely related trematodes, O. viverrini and C. 
sinensis [13,15]. Peroxiredoxin, GST and FABP are secreted by F. hepatica via non-classical 
secretory pathways, perhaps as cargoes of exosomes [37], into the host circulation where they 
influence host immune responses by recruiting and activating M2 macrophages [7,48,49] and 
suppressing dendritic cell activity [50]. These immunomodulatory effects contribute to the 
establishment of an immune suppressive environment, which aids parasite survival and the 
development of chronic disease. 
Defence against chemical toxins, including those generated by the immune response, is 
essential in allowing helminths to adapt to, and survive in, the host environment. This is 
mediated in large part by the three-phase drug detoxification pathway; Phase I (activation), 
Phase II (conjugation) and Phase III (efflux). This pathway also acts to reduce drug activity 
and/or bioavailability and has been linked with TCBZ resistance [41,51-53]. Until now only 
indirect evidence existed for the presence of Phase I cytochrome P450 (CYP 450) genes in F. 
hepatica [54]. Here, we report that the F. hepatica genome contains two Phase I CYP 450 
gene models, one monooxygenase and one reductase; both are present in S. mansoni but only 
the reductase is found in C. sinensis. Basal expression levels did not reveal significant 
changes throughout development (Figure 6). Our analysis reveals that of the Phase II GSTs, 
the cytosolic GSTs were represented in the F. hepatica genome by at least seven separate 
genes comprising four different classes; four mu, one omega, one sigma and a putative novel 
zeta class. Zeta class GSTs demonstrate different activities to other GSTs and their role in 
helminths is poorly understood [55]. Comparison with S. mansoni and C. sinensis revealed 
this zeta class GST is unique to F. hepatica. Within the Phase III pathway [56,57], we 
identified 18 ATP-Binding Cassette (ABC) and five Multidrug and Toxic compound 
Extrusion (MATE) transporters in F. hepatica, similar to that found in S. mansoni and C. 
sinensis. Although no significant developmental changes in gene expression were observed 
for the cytosolic GSTs, we found that two microsomal GSTs and several putative multidrug 
resistance proteins were up-regulated in the immature and adult stages (Figure 6 and 
Additional file 15: Table S12) supporting the importance of broad-spectrum detoxification 
Phases in mediating defence against host-immune-mediated toxic assault and targeting via 
anti-parasitic drugs. 
Figure 6 Expression of detoxification genes. Expression of Phase I, II and II detoxification 
genes through development relative to metacaercariae. 
Conclusions 
The F. hepatica genome is one of the largest pathogen genomes sequenced to date but we 
found no evidence of genome duplication or repeat expansion to explain this. Why this large 
genome should have evolved is unclear, especially given that its replication may be 
energetically costly or slow cell division [58]. For a parasite, such as Fasciola, that relies on 
the production of large numbers of eggs to facilitate transmission, one would expect strong 
selection against the accumulation of junk DNA if a large genome imposed a cost on egg 
production. It is possible that much of the non-coding portion of the F. hepatica genome is 
involved in gene regulation [59], and the size of F. hepatica’s genome may be related to its 
complex life-cycle and variety of developmental morphs. If so, however, it would be difficult 
to explain why the F. hepatica genome is around three time the size of the Schistosoma 
genome [11], which has a similar life-cycle. The large genome of F. hepatica therefore 
remains a paradox for which we may have to wait for comparative genome sequencing, 
currently underway [60], across other platyhelminth taxa to provide an answer. 
The ability of F. hepatica to infect and survive in different tissue environments as it migrates 
from the intestine, through the liver and into the bile ducts is underpinned by gene 
duplication. Thus, our results show that, across the whole transcriptome, the strongest 
patterns of differential expression were observed among members of protease and tubulin 
gene families, and, in the case of proteases, these can be associated with changes in the active 
site and substrate specificity. While gene duplication appears to be a key process of 
adaptation to the parasitic life-style used by many helminths, it is notable that different 
helminth taxa have arrived at different evolutionary solutions. Comparison between F. 
hepatica and the bile-dwelling liver flukes C. sinensis and O. viverrini, shows the expansion 
of the anti-oxidant SOD families [13] and cathepsin F protease families [13,61] in C. sinensis 
and O. viverrini but not in F. hepatica, and conversely the expansion of the cathepsin L 
family in the latter species only, which suggests differences in how these related parasites 
tackle life within the same environment. Differences in the specificity or developmental 
expression of detoxification genes, such as members of the ABC and MATE families, or of 
the tubulin gene family, may be important in understanding why F. hepatica responds so 
markedly different to drugs at different stages of development compared to other digeneans. 
The exclusive activity of TCBZ against F. hepatica, and the potency of praziquantel to all 
these other digeneans except F. hepatica, points to a uniqueness in this parasite that needs to 
be resolved [37]. 
Fasciola hepatica is a highly adaptable parasite, evidenced by its ability to infect novel hosts, 
and it is notable that our results reveal high levels of polymorphism in genes specific to 
parasitic digeneans. Diversity within F. hepatica populations at genes important for the host-
parasite interface may underpin a high evolutionary potential for F. hepatica to respond to 
changes in host availability or to other selection pressures. Similarly, the broad geographic 
range of F. hepatica would suggest that it is able to adapt to different climatic conditions and, 
in this respect, F. hepatica may also be able to respond to exploit changes in climate in 
temperate regions, such as the UK, where warmer and wetter winters favour transmission and 
increased prevalence [62]. F. hepatica is seen to rapidly develop drug resistance to TCBZ 
[52] and the standing genetic diversity that we find across the genome suggests that it 
harbours the potential to evolve resistance to any novel drug treatment, which compounds the 
difficultly of controlling F. hepatica given the shortage of drugs effective against the juvenile 
stages. Nevertheless, the availability of a genome for F. hepatica that we provide, plus the 
characterisation of early molecular events in infection should help support the development 
of novel drugs and vaccines, particularly against the migrating juveniles that cause much of 
the pathology. For example, RNAi-mediated knockdown of cathepsin L and B expression has 
been shown to prevent NEJs from crossing the intestine [45] and vaccine trials with cathepsin 
L1 have provided partial protection against infection and pathology [63]. The exploitation of 
a broader range of targets within the F. hepatica genome is now a priority given the 
widespread prevalence of resistance to TCBZ within F. hepatica populations. The 
commercial importance for agriculture to develop a replacement treatment to TCBZ may 
stimulate new treatments that could be translated to other important digenean parasites, 
including those of humans. 
Methods 
Source of parasite material 
Adult parasites from each of five isolates were used for genome sequencing: 1) FhepLivSP, 
from the laboratory maintained Shrewsbury isolate (Ridgeway Research, UK); 2) FhepLivS1, 
a clonal line derived from the Shrewsbury population; 3) and 4) FhepLivR1 and R3, clonal 
lines derived from two isolates recovered from sheep in Northern England naturally infected 
with F. hepatica and 5) FhepLivR2, a clonal line derived from a F. hepatica population from 
naturally infected sheep in South West Wales. For RNA sequencing, the following were 
used: 1) metacercariae and newly excysted juveniles (NEJ) at 1, 3 and 24 hours post 
excystment from a North American isolate (Baldwin Aquatics Inc., USA). 21 day old 
juvenile flukes were recovered from mice infected with the same isolate; 2) an adult parasite 
recovered from the bile ducts of cattle naturally infected with F. hepatica in Uruguay. All 
animal work was conducted with ethical approval from the Universities of Liverpool (UK) 
and McGill (Canada). 
Sequencing 
Approximately 10 μg of DNA from a single, adult fluke taken from the FhepLivS1 strain was 
used to prepare Illumina TruSeq fragment libraries and 26Gbp of 2 x 250 bp reads generated 
on an Illumina MiSeq (mean insert sizes 470 bp and 580 bp). Further individuals of 
FhepLivS1 were used to prepare Nextera Mate-Pair libraries (3Kbp and 10Kbp) and 
approximately 60 m 2x 100 bp Illumina reads from each library were generated. 
Approximately 200 μg of DNA prepared from several fluke of the FhepLivSP isolate, was 
used to construct 2Kbp, 5Kbp and 8Kbp mate-pair libraries, which were sequenced either on 
an Illumina GAII or HiSeq 2000. For each of the parasite isolates FhepLivSP, FhepLivS1, 
FhepLivR1, FhepLivR2 and FhepLivR3, DNA was isolated from a single adult; a fragment 
library was prepared and sequenced on a single lane of an Illumina HiSeq 2000 to yield 
approximately 24Gbp of sequence (Centre for Genomic Research, Liverpool, UK). For RNA 
sequencing, Illumina TruSeq RNA libraries were prepared from biological replicates of 
metacercariae (3 replicates), NEJ 1 hour (2 replicates), NEJ 3 hours (2 replicates), NEJ 24 
hours (2 replicates), Juveniles 21 days (1 replicate) and Adult (1 replicate) (Genome Quebec, 
Montreal, Canada). 
Assembly and annotation 
Illumina MiSeq reads were trimmed to Q ≥ 30 and adaptors removed using Sickle and Perl 
and assembled using Newbler (Roche GS-Assembler v2.6) with flags set for large genome 
and a heterozygote sample. Mate-pair reads were first mapped to these contigs using Bowtie2 
[64] to remove duplicates and wrongly orientated reads, and scaffolded into contigs using 
SSPACE [65]. Gap filling was achieved using GapFiller for 2x 250 bp and 2x 100 bp paired-
end reads and run for three iterations (available as ENA accessions LN627018-LN647175). 
RNAseq data were mapped to scaffolds within the assembled genome greater than 3Kbp 
using TopHat2 to identify transcribed regions and splice junctions. These, together with 
RNAseq data assembled using Trinity and S. mansoni protein sequence, were passed to the 
MAKER pipeline [66] to predict genes. Repeatmasker, Windowmasker and Dustmasker were 
used to identify repetitive regions. CEGMA v2.4 [67], which searches for 248 highly 
conserved genes, was used to assess the completeness of genome with the settings for 
vertebrates to allow long introns. REAPR [68] was used to assess the quality of scaffolding 
within the assembly and to produce an alternative, more conservative assembly by splitting 
scaffolds at locations with lower support (available as ENA accessions LN736597-
LN774150). Homologs of F. hepatica predicted protein sequences were identified within 
UniProt using BLAST and functional domains identified using InterPro. InParanoid and 
MultiParanoid [69] were used to identify ortholog clusters from Schistosoma mansoni 
(v3.1.16), Clonorchis sinensis (v3.7), Schmidtea mediterranea and Echinococcus 
multilocularis (v29042013) predicted proteins [11-15,70]. 
Gene expression analysis 
RNAseq libraries were mapped to MAKER gene models using TopHat2 [71] and read counts 
extracted using htseq-count. Genes with a sum of at least five reads across all libraries were 
analysed for differential expression in edgeR [72] using a negative binomial model of 
successive developmental stages relative to metacercariae and with tagwise dispersion 
estimated from all samples. Hierarchical clustering, based on model coefficients, was used to 
group differentially expressed genes by similarity of expression into 12 clusters and 
hypergeometric tests used to test for over-representation of gene ontology terms within each 
cluster relative to the whole gene-set. 
Genetic diversity analysis 
Reads for each isolate were mapped to the genome using Bowtie2 and resulting bam files 
passed together to the GATK pipeline [73] for local realignment and SNP calling. SNP calls 
within genes were filtered by score >100, FS <60 and combined coverage between 10 and 
250. Because gene duplicates collapsed within the assembly might give erroneously high 
diversity for some genes, genes were excluded with a median coverage greater than 213 and 
by heuristic scoring of SNPs appearing as heterozygotes in all samples. IGV was used to 
manually assess the success of filtering parameters. Levels of nucleotide diversity for 
different classes of SNPs were calculated for all genes. To identify the most polymorphic 
genes, a generalised linear model with a Poisson distribution was fitted to the number of non-
synonymous SNPs as the response variable versus number of non-synonymous sites as a 
quadratic function. This accounts for the distribution of SNP counts within a gene, the fact 
that longer genes have the potential to have more SNPs and the possibility that genes of 
different lengths may evolve at different rates. Genes were classified according to their 
conservation across platyhelminths by the presence of orthologs retained across increasing 
taxonomic scales. This was preferred to assessing conservation on the basis of non-
synonymous versus synonymous substitution ratios between species, since synonymous sites 
were saturated by multiple substitutions at such broad taxonomic scales. The robustness of 
the generalised linear model was tested by randomly sampling equal proportions of genes 
from each quartile of the length distribution for each class of conserved gene, to ensure that 
no bias was introduced if the length of a gene was correlated to its level of conservation. 
From the generalised linear model, the most polymorphic genes were identified having 
residuals in the top 1% quantile and hypergeometric tests were used to test for over-
representation of GO terms within these highly polymorphic genes relative to the gene-set as 
a whole. 
Discovery and characterisation of gene families 
Discovery of F. hepatica gene families was carried out using BLAST analysis (NCBI v2.2.27 
& v2.2.29), with available published gene sequences of interest (Additional file 16: Table 
S13), followed by manual annotation. Comparative analysis was carried out using the closely 
related trematode genome sequence datasets: Clonorchis sinensis and Schistosoma mansoni. 
Sequence alignment and phylogenetic analysis was carried out using Clustal Omega [74] and 
MEGA5 [75] respectively. 
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under accessions LN627018-LN647175 (assembly data), PRJEB6687 (genomic read data) 
and PRJEB6904 (transcriptomic read data). 
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